Click here to see this online
 
 
 

February 7, 2019

 
 
NEWS
 
 
 

Aditi Das Receives Young Investigator Award from American Society for Nutrition
Aditi Das, assistant professor in comparative biosciences, was recently named the 2019 recipient of the Mary Swartz Rose Young Investigator Award from the American Society for Nutrition. This award recognizes an investigator who is within 10 years of postgraduate training and who has contributed outstanding research on the safety and efficacy of bioactive compounds for human health. Read more

 
 
 

CCIL Director Rohit Bhargava Featured on The News-Gazette's Campus Conversation Podcast
The News Gazette's Julie Wurth talks with CCIL Director Rohit Bhargava about its plan to win designation as a National Cancer Institute and the potential benefits for students, researchers and cancer patients. Read highlights from the podcast here. Click below to listen to the entire discussion.

 
 
 
 
 
 

Stephen Boppart Wins the 2019 SPIE Biophotonics Technology Innovator Award
Stephen Boppart, professor of bioengineering and electrical and computer engineering and CCIL member, received the 2019 SPIE Biophotonics Technology Innovator Award. This award is presented for extraordinary achievements in biophotonics technology development that show strong promise or potential impact in Biology, Medicine, and Biomedical Optics. The award targets achievements that span disciplines and may include elements of basic research, technology development, and clinical translation. Read more.

 
SAVE THE DATE: RESEARCH ADVOCACY DAY

Join Us for Cancer Research Advocacy Day
Mark your calendars for May 17 for Research Advocacy Day hosted by the CCIL's Cancer Research Advocacy Group (CRAG) at the I-Hotel and Conference Center. The event is a way to promote interactions between cancer survivors, researchers, and clinicians and honor those who have been impacted by the disease. More details to come.

 
 
UPCOMING EVENTS

February Faculty Seminar Series
Join us for February's Faculty Seminar Series on February 21, 2019, from 3:00 to 4:00 p.m. at Beckman Institute (Room 4269) featuring Hong Jin, Assistant Professor of Biochemistry, and Bo Wang, Assistant Professor of Comparative Biosciences. Learn more.

 
 
 
 
 

Inclusive Lab Leaders Workshops Start February 8th
The Inclusive Lab Leaders workshops are a new program by the 21st Century Scientists Initiative at the Beckman Institute for Advanced Science and Technology. The goal of this program is to help PIs—new and veteran—become more effective at managing their research groups. There will be four sessions, all on Fridays from 9:30-11:30 a.m. at Beckman; coffee and fruit will be provided. Learn more.

 
 
 
 

Molecular and Integrative Physiology Seminars
Myeloid-Derived Suppressor Cells and Cancer
March 7, 2019
11:00 a.m.
Charles Miller Auditorium, B102, CLSL

Dmitry Gabrilovich, MD, PhD
The Wistar Institute

Tumor Microenvironment and Dormancy
March 28, 2019
11:00 a.m.
Charles Miller Auditorium, B102, CLSL

Cyrus Ghajar, PhD
Fred Hutchinson Cancer Research Center

 
CALL FOR PROPOSALS

Cancer Center at Illinois Seed Funding Call for Proposals 
The CCIL Seed Funding program provides support for Illinois cancer research teams, with the expected outcome of a fundable interdisciplinary research proposal. The CCIL anticipates funding two or three interdisciplinary research proposals during the 2018-2019 cycle. Learn more about eligibility and deadlines here. 

 
 
 EXTERNAL FUNDING OPPORTUNITIES

FY19 Breast Cancer Research Program
DOD
Deadlines Vary 

Lloyd J. Old Start Program
Cancer Research Institute
Deadline: March 1, 2019

Damon Runyon Cancer Research Foundation Fellowship Program
Damon Runyon Cancer Research Foundation
Deadline: March 15, 2019

ACS Research Grants
The American Cancer Society
Deadline: April 1, 2019

1. Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed)
2. Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed)
National Institutes of Health
Deadline: September 27, 2019

1. Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed)
2. Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed)
National Institutes of Health
Deadline: September 27, 2019

1. Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional)
2. Revisions for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional)
3. Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional)
National Institutes of Health
Deadline: September 27, 2019
 

**New** Provocative Questions (PQs) in Cancer with an Underlying HIV Infection (R01 Clinical Trial Optional)
Department of Health and Human Services
August 3, 2020

 
 

If you received an award, published a paper, or have news to share, we want to hear from you.
Send your news items to cancercenter@illinois.edu

Visit the Cancer Center Events Calendar
for upcoming cancer-related activities and events.

Follow us on Twitter at @CancerCenterIL.


cancer.illinois.edu | cancercenter@illinois.edu | @CancerCenterIL